Shaza Zayzafoon-Mosier, MD
Hospitalist · Kalamazoo, MINPI 1255304358
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $628 of the $698 with a category attached, or 89.9%. 9 manufacturers reported payments, led by Merz North America, Inc. at 34.6% of the total. Reporting peaked in 2022 at $239 and has fallen 93.5% since, to $16 in 2025.
Across 31 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$241
- AbbVie$220
- Johnson & Johnson$83
- GSK$47
- Melinta Therapeutics, LLC$35
- E.r. Squibb & Sons, L.L.C.$28
- plus $43 from 3 others
What the payments were for
- Food & beverage$62890%
- Education$7010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 4 | $241 |
| AbbVie(2 entities) | 12 | $220 |
| Johnson & Johnson | 5 | $83 |
| GSK | 3 | $47 |
| Melinta Therapeutics, LLC | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Novartis | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
How this compares
$698 in reported general payments places this provider in the 85th percentile of 342 hospitalist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $8,811 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $228 |
| Prednisone | 22 | $94 |
| Metoprolol Tartrate | 14 | $87 |
| Pantoprazole Sodium | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Kalamazoo
- Tamim SalmanKalamazoo$2K
- Lukasz NiecKalamazoo$2K
- Camelia MeratiKalamazoo$900
- Xiaorong YanKalamazoo$604
- James MackayKalamazoo$600
- Scott KaatzDetroit$146K
- Zakhria BelasherWarren$31K
- Johnathon MarkusClinton Twp$17K
- Neetu TalrejaDetroit$16K
- Cecilia NguyenRoyal Oak$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.